







PARENTAL CONSCIENTIOUSNESS AND EFFECTIVE DISEASE MANAGEMENT IN 












A thesis submitted to the faculty at the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Master in Science in the Clinical Rehabilitation 















     Eniko Rak 
 
          Eileen Burker 
 


































ALL RIGHTS RESERVED 
 







Kendall Clay: Parental Conscientiousness and Effective Disease Management in Children with 
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Type 1 diabetes is a chronic health condition that requires treatment adherence to avoid 
severe complications. This study examined the relationship between caregiver conscientiousness 
and the quality of diabetes management provided to the child. A total of 30 parents of children 
with diabetes in a Southeastern US Pediatric Endocrinology Clinic participated in a cross-
sectional study. Demographic information, patient A1C scores, caregiver conscientiousness 
levels, and caregiver treatment adherence were assessed. Participants were divided into two 
groups based on the child’s A1C scores. Caregiver’s conscientiousness scores were not 
associated with A1C scores of the child. Caregivers’ treatment adherence scores did predict A1C 
scores. Preliminary findings suggest that while parental conscientiousness may not predict the 
child’s A1C score, caregivers’ treatment adherence did. Thus, parents are aware of proper 
treatment, and if they pursue it, the child will benefit. Adherence may reflect facets of 
conscientiousness such as the ability to work diligently, be responsible, and obey the rules. 
Keywords: T1D, type 1 diabetes, adherence, parent or caregiver conscientiousness, 
diabetes management 
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In the United States (U.S.), around three million individuals have type 1 diabetes 
(Brinkman, 2017). The incidence of T1D is around 1.93 per 1,000 youths (Dabelea et al., 2014). 
This disorder results from a misused autoimmune reaction toward the beta cells within the 
pancreas. Healthy beta cells develop insulin, a hormone which regulates the amount of sugar 
within the bloodstream by enabling that sugar to enter the body’s cells and be converted into 
energy (Brinkman, 2017). When the body attacks the beta cells of the pancreas, the organ cannot 
perform its essential function, and the sugar will build up within the bloodstream, leading to 
severe complications such as hyperglycemia (Karlsson et al., 2000). Type 1 diabetes (T1D) is a 
chronic condition that requires constant monitoring and management (Brinkman, 2017). The 
management of type 1 diabetes involves daily blood sugar monitoring, insulin injections, and 
maintenance of a strict diet and exercise regimen.  
There are racial/ethnic significant disparities in the prevalence of diabetes in the U.S. 
White individuals experience the highest prevalence rate of T1D in the U.S. at approximately 
2.55 per 1,000 (Dabelea et al., 2014). Black individuals experience a prevalence rate around 1.57 
per 1,000 (Mayer-Davis et al., 2009). For Asian individuals, the rate is generally 0.64 per 1,000 
(Liu et al., 2009). These differences indicate racial disparities in T1D occurrence. Without 
accounting for racial identification, in the U.S., around 1.93 out of every 1,000 individuals will 





The incidence rate of T1D peaks between the ages of 10 and 14 (Maahs et al., 2010). 
However, pre-adolescent youth still receive this diagnosis at an increasing rate. European 
registries suggest that current incident rates are highest for the 0-to-4 years age bracket (Maahs et 
al., 2010). In addition, for children under the age of 14, this incidence risk is increasing by 3.4% 
on average for every year (Lawrence & Mayer-Davis, 2019). Thus, more young children are 
receiving a T1D diagnosis. Given the demanding nature of T1D, young children cannot manage 
this disorder without assistance from a caregiver; children under age ten will be dependent on the 
parent for treatment regulation. Children below this age should not administer insulin shots, 
decide when to give injections, or control their diet (Schwartz, 2013). While they can start 
recognizing low blood sugar, their judgments will not be consistently accurate (Gonder-
Frederick et al., 2008). Furthermore, a child age ten or below will not understand how to adapt 
target blood sugar ranges for activity and meals (Schwartz, 2013). In addition, since incidence 
rates peak between age 10 and 14, children age 10 or under with T1D will not be far from their 
age of diagnosis (Maahs et al., 2010). With less time since diagnosis, as well as the young age of 
the child, self-management will be a challenge; thus, the parents are responsible for management. 
For optimum treatment, the primary caregivers are expected to be disciplined, responsible, and 
industrious, as well as conscientious in their attitudes and actions. Conscientiousness is the 
ability to control impulses, work diligently, be responsible, and obey the rules (Roberts et al., 
2014). 
Since proper T1D management can delay or prevent complications or disease 
progression, management and adherence to treatment is of utmost importance. In order to 
support optimal care, facilitators and barriers to treatment must be carefully evaluated and 





adherence and effective management, but there is a gap in research describing the role of 
caregiver conscientiousness. The aim of the current study is to examine the role of parental 
conscientiousness in the child’s diabetes management. A better understanding of these 
relationships would be critical in treatment planning when the patient is a young child. Findings 
could help promote programs to increase caregiver conscientiousness in order to improve the 
child’s diabetes management. Finally, this research could promote future investigations into the 
relationships between caregivers and care-receivers, based on any aspect of a caregiver’s 
personal qualities.  
Type 1 Diabetes Treatment  
 Type 1 diabetes is a lifelong disease. Once two or more autoantibodies develop, the 
pancreas will never recover from its autoimmune deficiency (“T1D Facts”, n.d.). In order to 
regulate the body’s blood sugar levels, the individual requires an ongoing regimen consisting of 
glucose monitoring, insulin injections, and diet alterations. These treatments are highly nuanced, 
susceptible to change, and mentally demanding for the parent and the child.  
 T1D is diagnosed through blood testing, ketone checking, and pancreatic autoantibody 
detection (“Type 1 Diabetes in Children”, n.d.). Hemoglobin A1C levels above 6.5% indicate an 
abnormally elevated blood sugar level over the past months (“Type 1 Diabetes in Children”, 
n.d.). To detect pancreatic autoantibodies, a blood sample is examined (Brinkman, 2017). 
Finally, for ketone detection, the blood sample will show if the body is producing ketones for 
energy production. These ketones will only develop if the body’s cells are not receiving enough 
glucose, which is a primary indicator of a non-functioning pancreas (Albanese-O’Neill et al., 





Given T1D’s chronic nature, the management plan is ongoing and ever-adapting, due to 
potential changes in technology and medical knowledge (Bulsara et al., 2004). Currently, for 
medical maintenance, an individual with T1D under age nineteen will need to monitor 
hemoglobin A1C levels every three months (Brinkman, 2017) to ensure it remains below 7.5% 
(“Type 1 Diabetes in Children”, n.d.; Chiang et al., 2014). Blood glucose testing occurs around 
six to ten times each day (Brinkman, 2017). Testing is recommended before bedtime, prior to 
eating, prior to exercise, after a critical spike in glucose, and prior to potentially dangerous tasks 
where diabetic episodes could be harmful (Brinkman, 2017). The child’s blood glucose levels 
should fall between 70mg/dL and 120mg/dL (“Blood Sugar”, n.d.). In order to keep levels within 
this range, the parent should inject the child with an appropriate dosage of insulin at specific time 
intervals. Abnormal readings must be addressed. For typical insulin injection routines, the child 
receives around half of their total insulin dosage through “basal” injections. Basal insulin is a 
longer lasting insulin which provides a constant supply of insulin to lower the blood glucose 
levels of an individual with diabetes (“Basal Bolus”, n.d.). To complement the basal dosages, the 
child will also receive “bolus” injections, typically around mealtimes or during spouts of high 
blood glucose levels. This type of insulin will have a more powerful but shorter effect on the 
individual’s blood glucose level (“Basal Bolus”, n.d.). Together, this basal-bolus therapy is 
considered the gold-standard of self-injection T1D treatment (Brinkman, 2017). With basal-bolus 
therapy, the caregiver must keep both forms of insulin ready for the child, administer shots at 
specific times throughout the day, and respond to blood glucose checks with the appropriate 
form of insulin injection. Evidently, insulin therapy is extremely complex and requires constant 





Recently, new devices were introduced to assist with insulin injections. These “smart 
pumps” or artificial pancreases, administer basal and bolus doses in response to recorded glucose 
levels. Even with these advancements, the American Diabetes Association advises parents to 
remain vigilant and “test the blood sugar four to eight times a day to check the pump’s 
effectiveness, adjust mealtime boluses, and correct high blood sugar levels” (“Is an Insulin 
Pump”, n.d.).  Since young children cannot manage their own pump usage, parents provide 
supervision to regulate insulin administration and deal with any potential pump problems. 
Furthermore, these insulin pumps need to be replaced every 2-3 days, as well as be reloaded with 
more exogenous insulin (“How to Use”, n.d.). Therefore, even with the availability of assistive 
devices, parents continue to be primarily responsible for the child’s diabetes management.  
 Management also involves diet regulation and exercise. A registered dietician assists 
families with developing an individualized dietary regimen (“Food and diet”, n.d.). These 
guidelines will require the parent to learn and utilize knowledge about carbohydrates, fats, and 
proteins. For example, carbohydrates are readily broken down into glucose for energy usage, 
which can lead to blood sugar spikes. The parent must learn how much insulin will be required to 
regulate these surges (“Food and diet”, n.d.). Fats will delay absorption of glucose into the 
bloodstream, which can lead to hypoglycemic episodes immediately following a meal (Paterson 
et al., 2015). On the contrary, high-fat meals can lead to hyperglycemic episodes later, several 
hours following a meal (Paterson et al., 2015). This is particularly dangerous, since higher fat 
diets have increased in popularity within the American diet (Smart, King, & Lopez, 2020). While 
dietary planning from endocrinologists or dietitians can help parents cook diabetes-friendly 
meals, alterations in blood sugar level can still be burdensome on parents because of the 





hyperglycemia after a high-fat dinner). Finally, protein consumption leads to hyperglycemia two 
to three hours following a high-protein meal; this hyperglycemic state can sustain itself for more 
than five hours (Paterson et al., 2015). This results from the slow conversion of amino acids into 
glucose, which creates a steady, prolonged increase in blood glucose levels (Smart, King, & 
Lopez, 2020). The parent must gauge these micronutrients to adjust bolus injections throughout 
the day. Yet, it is difficult to precisely estimate a meal’s effects on glucose levels. Thus, dietary 
management places a strong pressure on the parent to learn and execute their knowledge 
accurately.  
 In addition, exercise adds another management component. Exercise is linked to reduced 
insulin requirements in individuals with T1D (Turner et al., 2015). It increases an individual’s 
insulin sensitivity, as well as incites muscle glucose intake, leading to lowered doses of bolus 
injections (Tonoli et al., 2012). Furthermore, chronic aerobic exercise is linked to a significant 
decrease in A1C values in pre-adolescent children (Tonoli et al., 2012). While a reduced need for 
insulin and lowered A1C value may ease diabetes management, exercise still poses a challenge 
for blood sugar regulation. Aerobic and anaerobic exercise can evoke different glycemic 
reactions in individuals with T1D. For example, aerobic exercise may lead to hypoglycemia, 
while anaerobic exercise may lead to hyperglycemia (Turner et al., 2015). Bolus injection 
dosages must be adjusted in response to these outcomes. High-intensity exercise will require 
insulin for lowering glucose levels; prolonged exercise will require the forethought of insulin 
reduction (Turner et al., 2015). Due to the responsive nature of blood glucose to exercise, the 
caregiving parent must be knowledgeable and prepared to properly regulate their child’s glucose 






 Health Consequences of Ineffective T1D Management  
Poorly managed diabetes increases the risk of significant health problems. Levels of 
blood sugar may become hazardously low or high. Low levels cause hypoglycemia, manifested 
in weakness, dizziness, shakiness, irritability, nausea, hunger, sweating, and a fast heartbeat 
(“Type 1 Diabetes Complications”, n.d.). With hypoglycemia, the child’s blood glucose levels 
have fallen below 70mg/dL (Morales & Schneider, 2014). Hypoglycemia causes sweating, 
confusion, tremors, palpitations, and hunger; in children, hypoglycemia is primarily noticed 
through mood or behavioral changes (Lehecka et al., 2012). Repeated hypoglycemic episodes are 
associated with cognitive impairments, decreased quality of life, and increased risk of mortality 
(Morales & Schneider, 2014). Younger children are at a higher risk for hypoglycemia than adults 
(Cengiz et al., 2014; Juvenile Diabetes Research Foundation et al., 2011). Children with T1D 
cannot consistently recognize a hypoglycemic episode; in fact, they fail to detect almost half of 
those (Lecheka et al., 2012; Gonder-Frederick et al., 2008). In addition, parents also miss 
hypoglycemic readings more than 50% of the time (Gonder-Frederick et al., 2008). Given these 
dangerous statistics and detrimental health consequences, it is vital for the parent to monitor 
insulin dosages, keep fast-acting carbohydrates around to combat hypoglycemia, and consistently 
check the child’s glucose to make a correction before it falls into severe hypoglycemia.  
Hyperglycemia also can be extremely hazardous. Hyperglycemia exists when the child’s 
blood glucose levels rise above 240mg/dL (“High Blood Sugar”, n.d.). This condition causes 
excessive thirst, frequent urination, tiredness, weight loss, and blurred vision (“Type 1 Diabetes 
Complications”, n.d.). If hyperglycemia remains prolonged and occurs frequently, the child may 
develop ketones in the blood. These ketones develop because the glucose cannot enter the body’s 





(Albanese-O’Neill et al., 2017). To check for these ketones, the caregiving parent may use urine 
ketone test strips or blood ketone meters on the child (Albanese-O’Neill et al., 2017). In 
particular, compared to adults with T1D, children are more likely to have increased ketone 
production during periods of fasting (Wadwa et al., 2016). Given this increased elevation of 
ketone production for youth with T1D, prompt detection and treatment of hyperglycemia is 
crucial for preventing diabetic ketoacidosis (Wadwa et al., 2016). Diabetic ketoacidosis occurs 
when the excess of ketones causes the blood to become acidic (“Diabetic”, n.d.).  Left untreated, 
this condition can lead to a diabetic coma and potentially mortality (“Diabetic”, n.d.). 
Furthermore, diabetic ketoacidosis can cause cerebral edema, particularly in children with T1D 
(“Diabetic”, n.d.). Therefore, the child needs routine blood sugar checks, insulin corrections, and 
occasional ketone checks of the urine to control hyperglycemia. In addition, the parent must 
maintain diabetes equipment, procure supplies from insurers, schedule medical appointments, 
and buy desirable food products for the child’s disease management. Without these precautions, 
the child with T1D could suffer from the health complications of both high and low blood 
sugars.  
Conscientiousness and Health Behaviors  
Our health behaviors are heavily influenced by our personal characteristics (Raynor & 
Levine, 2009). Conscientiousness is linked to positive health outcomes (Raynor & Levine, 
2009). Conscientiousness is defined as “the propensity to be self-controlled, responsible to 
others, hardworking, orderly, and rule abiding” (Roberts et al., 2014, pg. 1). This construct is 
composed of six main factors: responsibility, order, virtue, industriousness, self-control, and 
conventionality (Green et al., 2016). This trait was originally part of the Big Five taxonomy of 





Conscientiousness demonstrates a strong association with overt health behaviors (Raynor & 
Levine, 2009).  
Broadly, conscientiousness deals with how the individual controls his or her impulses, 
becomes goal-directed, plans, and follows rules (Boggs & Roberts, 2004). Much of this construct 
involves aspects which directly relate to health behaviors. Individuals who are higher in 
conscientiousness have better health outcomes (Bogg & Roberts, 2004). They have lower drug 
and alcohol usage, lower rates of obesity, and higher rates of exercise (Bogg & Roberts, 2004). 
In addition, they have lower overall mortality rates (Roberts et al., 2014).  
While this link between individual conscientiousness and individual health behaviors 
might be readily supported by research (Bogg & Roberts, 2004; Raynor & Levine, 2009; 
Goodman & Friedman, 2006; Hampson et al., 2007), there was less of a focus on the caregiver’s 
conscientiousness and the quality of care provided to the person affected by the disease. Since 
diabetes management for young children requires extensive support from the parent, the parent’s 
personality trait of conscientiousness could impact how well the child’s treatment is maintained. 
In a similar study with caregivers of individuals with Parkinson’s disease, having a caregiver 
with higher conscientiousness scores was associated with having a patient with higher quality of 
life scores (Ma et al., 2018). Additionally, a study on older couples measured spousal 
conscientiousness on the sick partner’s health outcomes. These couples experienced 
compensatory conscientiousness, where a highly conscientious spouse led to better health 
outcomes in their partner (Roberts et al., 2009). These authors theorized that highly 
conscientious spouses might be better caregivers (Roberts et al., 2009). The aim of the current 
study is to investigate if high conscientiousness scores in parental caregivers is related to the 





While the literature is scarce with regards to parental conscientiousness and its 
relationship with the child’s disease management, similar constructs demonstrate promising 
correlations (Paschal et al., 2015; Weinstock et al., 2015). For example, parental health literacy 
predicts better disease management (Paschal et al., 2015). To become effective, parents must 
learn about the medical condition, understand available services for the condition, and effectively 
utilize this information to provide care (Paschal et al., 2015). While conscientiousness and 
parental health literacy are not the same, conscientiousness will likely influence the parent’s 
willingness to learn about the child’s condition and medical services, and their motivation to 
become proficient in medical self-management and care. For instance, a study on health literacy 
and personality traits found that odds for low health literacy decreased by 51% for individuals 
with above-average conscientiousness (Kim, Zhang, & Svynarenko, 2017).  
Parental literacy is a predictor of healthcare utilization for children with chronic kidney 
disease or end-stage kidney disease (Rak et al., 2016). Children whose parents had higher 
literacy skills experienced fewer emergency room visits compared to children of parents with 
lower literacy levels (Rak et al., 2016).  Additionally, parental health literacy is a predictor of 
health outcomes in children with epilepsy (Paschal et al., 2015). Caregivers with a stronger 
knowledge of epileptic symptoms had less instances of the child having seizures or missing 
medication doses (Paschal et al., 2015). The study also found that parental health literacy 
correlated with better disease management in the child. In other words, parents with higher 
health literacy, which corresponds with higher conscientiousness scores, have an increased 
likelihood of providing better care. Therefore, while the epilepsy study and kidney study differ 
from this current research study, they suggest some important trends which may be common 





Beyond parental health literacy, parental personality traits can impact treatment response 
in the child. While these studies do not focus on conscientiousness, they demonstrate a 
compensatory nature between parental traits and child disease management. For example, 
maternal personality traits moderate treatment quality in children with attention-
deficit/hyperactive disorder (Perez Algorta et al., 2020). Specifically, this study focused on 
neuroticism and conscientiousness in mothers and which treatment modality was the most 
efficacious for the child with ADHD (Perez Algorta et al., 2020). This study suggests that the 
parent’s personal characteristics impact treatment delivery, and subsequently, alter the child’s 
quality of care.  
Finally, parental conscientiousness has been linked to numerous behavioral outcomes in 
children, signifying a link between parental qualities and child outcomes (Nigg & Hinshaw, 
1998; Oliver, Guerin, & Coffman, 2009; Prinzie et al., 2005). A study on parental 
conscientiousness and adolescent behaviors found a reduction in adolescent externalizing 
behaviors if the parent had high conscientiousness (Oliver, Guerin, & Coffman, 2009). In this 
research, highly conscientious parents engaged in regular communication with their children 
about appropriate conduct, leading to positive behavioral outcomes. Although this link is not 
connected to health outcomes, it does highlight the relevance of parental conscientiousness on a 
child’s overall outcomes.  
 While the aforementioned study lacks a behavioral health component, a study on 
parental characteristics and outcomes of children with type 2 diabetes may demonstrate the link 
of transferable health skills between caregiver and child. Parents who were diabetic, had 
hypertension, were obese, and had depression were more likely to have children with similar 





children may also model health behaviors from their parents, leading to poor diabetes 
management within the youth population. For example, parents with type 2 diabetes who are 
unaware of proper diabetes management will not be able to model effective management 
behaviors for the child. Thus, while this study focused on juvenile type 2 diabetes management 
and physical characteristics of the parent, it could suggest a similar link between juvenile T1D 
management and the mental characteristic of parental conscientiousness. 
The current study on parental conscientiousness and effective management of T1D in 
children can advance understanding in this area. While the studies reviewed may suggest that 
health qualities can transfer from parent to child, they fail to examine parental personality as a 
potential factor. Therefore, this present study will investigate, in a sample of primary caregivers 
of children with T1D, the relationship between the caregiver’s conscientiousness levels and 
diabetes management in the child. It was predicted that parental conscientiousness scores would 
positively correlate with effective juvenile T1D management scores of the child.  
Method 
Participants 
Participants included 30 English-speaking primary caregiving parents (M age = 38.03 
range = 26-50, SD= 6.52, 93.3% females) of children age ten or under with T1D. The English-
speaking requirement was specified within the consent form. All participants were primarily 
recruited via three emails sent monthly over a three-month period. Additionally, the study 
attempted to contact all 106 potential participants via phone. In total, 33 individuals declared 
their interest in completing the study from the call. All of the participants’ children were served 
by the UNC Pediatric Diabetes Clinic. The clinic serves a diverse patient population in regards to 





the sample size required based on the power analysis (n= 42), calculated with a p-value of 0.05, 
an effect size of 0.15, and power of 0.8 (Faul et. al, 2009). Due to recruiting from a small pool of 
106 potential participants, data collection was ended when responses ceased for two weeks. After 
data collection was completed, all participants received a $10 Amazon e-gift card.  
The establishment of inclusion criteria based on the literature creates a more 
homogeneous group in terms of expected involvement and responsibilities in diabetes 
management. By limiting the child’s age to ten or under, the child’s own conscientiousness 
would not interfere with the effect of parental conscientiousness on T1D management (Orrell-
Valente et al., 2008; Schwartz, 2013). Additionally, by limiting the response to the primary 
caregiver, his or her conscientiousness scores will be more likely to impact the child’s diabetes 
management due to their more significant contribution to treatment.  
Procedure 
With assistance and permission from the UNC Pediatric Diabetes Clinic and Institutional 
Review Board, online questionnaires were distributed to parents. Eligible participant 
identification occurred using the clinic’s Epic system. The researcher recorded the email 
addresses of parents in a protected Excel spreadsheet. Additionally, each parent was assigned a 
group number based on the child’s A1C score. These groups consisted of an optimal A1C group 
(an A1C of 7.5% and below) and a suboptimal A1C group (above 7.5% A1C score) (Chiang et 
al., 2014). The group numbers, 1 and 2, were used to limit the amount of recorded medical 
information. Once initial screening was completed, potential participants received an email 
explaining the study and inviting them to participate. Within the email, the potential participant 
received a link to begin the pre-screening portion of the study. Since only the primary caregiving 





pre-screening survey. These two questions inquired if the parent attends to insulin injections and 
blood glucose monitoring more than fifty percent of the time, asserting their central role in 
management. If the individual was not the primary caregiving parent, the online study concluded 
and thanked them for their interest. If the individual was the primary caregiver, they were 
directed to the informed consent describing any risks to the participant, benefits of participation, 
and the individual’s right to terminate participation at any point. Following this electronic 
consent, he or she would begin one of the next two questionnaires. The primary caregiving 
parent would initially receive the IPIP Big Five Factor Markers, followed by the Self-Care 
Inventory. After finishing these surveys, participants received a short questionnaire regarding 
demographics and disease-specific information. Following this form, participants were properly 
debriefed through a short form and thanked for their responses. All completed responses were 
entered to receive a $10 Amazon e-gift card, which was disbursed after data collection was 
completed.  
Measures 
 IPIP Big Five Factor Markers for Conscientiousness. This scale was developed by 
Goldberg (1992) in order to measure each of the five domains that constituted the Big Five. 
These IPIP markers are easily applicable in research. Depending on the focus of research, 
subscales relevant for the research questions could be used in lieu of the full scale. Since 
participants receive a modest financial incentive of $10, it was pertinent to limit an undue time 
burden. Therefore, the respective subscale of conscientiousness was selected to be administered. 
This adapted IPIP measure is composed of 20 statements. Each statement is followed by a five-





conscientiousness include: “Am always prepared” and “Pay attention to details” 
(“Administering”, n.d.).  
 Values of answer choices range from 1 to 5. Every statement for conscientiousness was 
either positively or negatively keyed and reverse scored for total score computation by summing 
points assigned for individual items (“Administering”, n.d.). Scores on this measure can range 
from 20 to 100 with higher scores indicative of greater conscientiousness.   
 According to Goldberg’s analyses, the conscientiousness factor markers demonstrate a 
mean item intercorrelation of .27. The measure also holds adequate internal reliability,  = .88. 
Finally, this modified scale exhibited a .84 correlation with the overall marker of 
conscientiousness defined within the Big-Five factor structure (Goldberg, 1992; 
“Administering”, n.d.).  
 Self-Care Inventory Parent-Report 
The Self-Care Inventory (SCI) Parent-Report is a 14-item measure that the parent 
completes in reference to their child’s diabetes care. This scale was developed by LaGreca 
(2003), a pediatric psychologist for use in clinic and for research purposes. Participants report on 
their diabetes management behavior for the past one to two weeks. This questionnaire covers 
four domains of diabetes care: blood glucose monitoring, exercise, insulin injections, and diet 
(Lewin, 2009). Together, these four domains combine for one total adherence score. The 
behavioral adherence questions are rated on a five-point Likert scale. An answer of 1 
corresponds with “never do it”, while an answer of 5 corresponds with “always do this as 
recommended without fail” (Lewin, 2009). Higher scores indicate that the primary caregiver 





14 to 70, with higher scores indicative of greater adherence. Since this measure is short, 
completing it did not represent a significant time barrier for the participants.  
Given the varied regimen of diabetes management, the SCI-PR remains purposefully 
flexible. For example, an item on blood glucose monitoring can be applied equally to individuals 
with an insulin pump or a blood glucose monitoring system. In addition, this measure directs the 
participants to rate their behavior in reference to their child’s optimal treatment regimen, not in 
contrast to other potential treatments (Lewin, 2009). For example, while an insulin pump may be 
more precise than individual injections, the parent should rate his or her behaviors based on what 
the optimal insulin pump maintenance looks like, not as a comparison against more error-prone 
methods such as the individual injections.   
The SCI-PR has an internal consistency of  = .72 (Lewin, 2009). In previous studies, the 
scale demonstrated a moderate correlation of .41-.59 with a similar measure, the Diabetes Self-
Management Profile (Lewin, 2009). Furthermore, the SCI-PR exhibited a strong correlation of 
r=.91 between an original SCI-PR administration and a retest administration. Overall, the SCI-
PR displayed satisfactory validity and reliability results.  
Demographic Variables 
Demographic information may impact the relationship between caregiver 
conscientiousness and the child’s health outcomes. For example, a family’s financial status can 
impact the amount of resources available for the child’s health care (Currie, 2009). Parents with 
greater financial resources can ensure better quality medical care, nutritious food, and live in 
neighborhoods conducive to exercise safely outdoors (Currie, 2009). These advantages influence 
a child’s diabetes care, since a parent who can ensure healthy food, necessary trips to the doctor, 





Additionally, parents living under financial scarcity frequently deal with accompanying time 
scarcity (Strazdins et al., 2011). These individuals may lack the free time to regularly check their 
child’s blood glucose levels, cook nutritious meals, and engage in mutual exercise. Thus, this 
time scarcity can limit the parent’s ability to be actively and consistently involved in their child’s 
diabetes management throughout the day.  
Additionally, parental age can impact access to resources, as well as potential health 
literacy. Older paternal age is associated with increased social advantages for the child (Carslake 
et al., 2017). This includes elevated socioeconomic position, as well as increased access and 
connections to community resources. Additionally, children of older mothers, regardless of 
baseline child health, demonstrate better health outcomes than their peers (Zondervan-
Zwijnenburg et al., 2020). Therefore, this study includes parental age to check for the effect of 
these variables.  
 Furthermore, parental gender could influence child disease management. Mothers 
generally assume their child’s disease management (Gavin & Wysocki, 2006). Maternal 
monitoring in child’s T1D management has been associated with improvements in treatment 
adherence (Palmer et al., 2011). However, this adherence did not demonstrate a significant 
change in the child’s A1C score (Palmer et al., 2011). Additionally, only paternal monitoring 
was associated with lower A1C scores; however, paternal figures are typically less involved in 
the child’s disease management (Gavin & Wysocki, 2006; Palmer et al., 2011). Therefore, 
participant gender could impact the relationship between adherence and A1C scores.  
 Participant race is also important to consider. Previous research has demonstrated that 
minority youth are at an increased risk for elevated A1C scores compared to white youth (Jaser, 





lower levels of diabetes management monitoring than parents of white youth (Jaser, 2011). Thus, 
race/ethnicity could potentially contribute to the studied relationships.  
Therefore, participants will be asked for gender, age, ethnicity, race, and household 
income levels in a short form. This information was analyzed for interaction effects on the 
correlation between conscientiousness and the quality of diabetes management.  
Disease Specific Information 
Effective diabetes management involves a learning curve. Treatment becomes easier as 
time elapses from the age of diagnosis (Diabetes New Zealand, n.d.; 5 Facts, n.d.). In addition, 
older children can communicate with parents about blood sugar symptoms, decreasing a parent’s 
vigilance of care (Schwartz, 2013). Therefore, participants will be asked to give the age of their 
child and the age at which the child was diagnosed with T1D. With this information, data 
analysis can compensate for a varying range of participants’ experience and involvement with 
diabetes management. Additionally, since different treatment modalities could lead to improved 
A1C scores, participants will be asked to report the method of diabetes management (Šoupal et. 
al, 2016). This will include the options of self-injection, insulin pump, and artificial pancreas.  
Data Analyses 
 Pearson correlation tests, T-tests, multivariate linear regression, and logistical regression 
analyses were utilized to analyze associations between parental conscientiousness, Self-Care 
Inventory adherence scores, disease-specific information (age at diagnosis, time since diagnosis, 
treatment type), and sociodemographic variables (race/ethnicity, income level, gender, child age, 
parental age). We conducted three Pearson correlation tests between our three major variables of 
conscientiousness scores, adherence scores, and A1C levels to determine preliminary 





between conscientiousness scores and adherence scores for optimal and suboptimal A1C 
grouping. Additionally, three multivariate regressions were employed. The first assessed the 
primary research question of whether parental conscientiousness has a statistically significant 
effect on A1C levels of the child, controlling for disease-specific and sociodemographic 
variables. The second regression investigated whether parental conscientiousness has a 
statistically significant effect of adherence scores, again controlling for disease-specific and 
sociodemographic variables. Since previous literature has shown that adherence scores can affect 
A1C levels (Lewin et al., 2009), we wanted to investigate whether parental conscientiousness 
could affect this key metric. The third regression analyzed whether both conscientiousness scores 
and adherence scores had a statistically significant effect on A1C levels, controlling for disease-
specific and sociodemographic variables. Finally, three logistical regressions were performed. 
The first logistical regression assessed whether our primary independent variable of parental 
conscientiousness scores affects A1C group determination, controlling for disease-specific and 
sociodemographic variables. The second logistical regression analyzed whether adherence scores 
affect A1C group determination, again controlling for disease-specific and sociodemographic 
variables. The third logistical regression investigated whether both conscientious and adherence 
scores had a statistically significant effect on A1C group determination, controlling for disease-
specific and sociodemographic variables. While data on race and gender was collected, the 
inadequate diversity of the sample did not allow us to include these sociodemographic variables 
in our analysis. Significance was determined at P < 0.05 for all analyses. R studio was utilized 








Descriptive Statistics  
Overall, participant A1C scores ranged from 5.7 to 11.7. The mean A1C within this 
sample was 8.26, which falls within the suboptimal range. The standard deviation was 1.16.  
This study divided participants into two groups based on A1C scores. Scores of 7.5 or 
lower were placed within the optimal A1C group; scores above 7.5 were placed into the 
suboptimal group. Seven participants were added to the optimal group and twenty-three 
participants were added to the suboptimal group. For the optimal A1C group, scores ranged from 
5.7 to 7.5, with a mean of 6.914 and standard deviation of 0.696. For the suboptimal A1C group, 
scores ranged from 7.6 to 11.7, with a mean of 8.665 and standard deviation of 0.94.  
Conscientiousness scores ranged from 59 to 99, with a mean of 83.07 (SD 9.86). Given 
the structure of the IPIP Big Five Factor Marker for Conscientiousness Scale, this mean suggests 
that most participants endorsed above average levels. 
For the optimal A1C group, the conscientiousness score mean was 86.0, with a range of 
75-99, and a SD of 9.54. For the suboptimal A1C group, the conscientiousness score mean was 
82.17, with a range of 59-99 and a SD of 9.99. While these ranges varied, the mean scores 
between groups were relatively similar, as evident in Appendix H.  
 The Self-Care Inventory Parent Report provided diabetes management adherence scores. 
These adherence scores had a mean of 4.25, range from 2.53 to 5.00, and standard deviation of 
0.59. Based on this distribution, most parents endorsed following doctor recommendations more 
than half of the time. Scores were clustered toward the higher end of the scale, demonstrating 






For the optimal group, the adherence score mean was 4.54, the range was 3.86-5, and the 
standard deviation was 0.37. The suboptimal group demonstrated an adherence score mean of 
4.22, the range was 2.14-5.00, and the standard deviation was 0.73.  
General participant characteristics are available in Appendix A.  
Normality Assumption 
 Given the small sample size of 30, the researcher attempted to check for normality given 
that the Central Limit Theorem may not apply. In order to test this assumption, three Shapiro 
tests were employed on the main continuous variables of A1C, adherence, and 
conscientiousness.  
 For A1C, the Shapiro test indicated a p-value of 0.02. Adherence score exhibited a p-
value of 0.01. Conscientiousness score produced a p-value of 0.57. Therefore, normality can be 
assumed for conscientiousness score. However, normality cannot be assumed in adherence or 
A1C scores.  
 For A1C, the normality could be skewed due to the nature of A1C; abnormally high 
scores would result in serious health consequences. Therefore, it is reasonable that the right-side 
of the density plot would be short. For adherence scores, due to overly positive results, the 
density plot does not exhibit many scores on the left tail.   
Pearson Correlation Tests 
 In order to determine preliminary correlational relationships between the three main 
variables of conscientiousness, adherence, and A1C, three Pearson correlation tests were 
performed between each of these variables. A1C and conscientiousness scores produced a p-
value of 0.08. Between adherence and A1C scores, the p-value was 0.03. Conscientiousness 





has reason to complete more complex tests involving these variables to determine causality and 
account for potential exogeneity.  
Between Groups Comparisons 
When conducting a T-test between conscientiousness scores and the two A1C groups, the 
data produces a p-value of 0.38, indicating no statistically significant difference in means of 
conscientiousness scores between these two groups.  
 A T-test was similarly conducted for adherence scores and the two A1C groups. The data 
produces a p-value of 0.04, indicating a statistically significant difference between these two 
groups (see Appendix A).  
Linear Regression  
T-tests were performed between optimal and suboptimal groups designated by the 7.5 
A1C divider. However, A1C scores and their relevant health outcomes exist on a spectrum. 
While scores are encouraged to stay below 7.5, in reality, reducing A1C scores by any amount 
will be beneficial for an individual with T1D. Therefore, a linear model allows the researcher to 
uncover the marginal effect of these variables on A1C, regardless of their group jurisdiction for 
this study.  
Three regression models were performed using A1C and adherence scores as dependent 
variables. The independent variables used were conscientiousness scores, time since diagnosis, 
parental age, age of the child, treatment type, and income. For the regression utilizing A1C as the 
dependent variable, independent variables listed in Appendix B demonstrate no statistical 
significance on A1C levels. The primary independent variable, conscientiousness score, 





The second regression model utilized adherence score as the dependent variable. This 
analysis found a statistically significant effect between treatment type and adherence scores with 
a p-value of 0.03, as illustrated in Appendix C. 
The third regression model used A1C as the dependent variable but used both 
conscientiousness scores and adherence scores as the primary independent variables. 
Independent variables listed in Appendix D indicate no statistical significance. The association 
between A1C and the primary independent variables of conscientiousness and adherence scores 
was not significant (p=0.20; p=0.13). 
Logistical Regression 
 While the linear regression did not demonstrate statistical significance for the research 
hypothesis, this method predicts with continuous A1C. This study purposefully separated 
participants into an optimal A1C group and a suboptimal A1C group. Thus, three logistical 
regressions were performed to predict the log-odds of a child being placed into the optimal or 
suboptimal A1C group based on the independent variables of parental conscientiousness and 
adherence scores. 
Three logistical regressions were performed. With the first regression, the independent 
variables of conscientiousness score, time since diagnosis, child age, parental age, income, and 
treatment type were utilized. The second regression used the independent variables of adherence 
score, time since diagnosis, child age, parental age, income, and treatment type. The third 
regression used independent variables of adherence score, conscientiousness score, time since 
diagnosis, child age, parental age, income, and treatment type.  
All three logistical regressions showed no statistical significance between the dependent 






The present study examined the relationship between parental conscientiousness and T1D 
management in children age 10 and under. This relationship was important to examine, since the 
parent is the primary caregiver of the child’s disease management (Schwartz, 2013). Prior 
research has evaluated conscientiousness levels affecting one’s own disease management; 
however, the idea of compensatory conscientiousness is relatively new and insufficiently 
explored within empirical work (Roberts et al., 2009). There were several findings from the 
present study: (1) parental conscientiousness did not differ between optimal and suboptimal A1C 
groups with a 7.5 A1C cutoff, (2) A1C and adherence scores were significantly positively 
associated when comparing between groups, and (3) self-injection treatment type led to a 
significant drop in adherence scores compared to pump treatment.  
Parental conscientiousness scores did not demonstrate statistical significance between the 
optimal and suboptimal A1C groups. However, when conscientiousness was evaluated in a 
Pearson correlation with continuous A1C, conscientiousness demonstrated a p-value of 0.08 with 
A1C scores. Due to unevenly distributed groups with 7 participants in optimal and 23 
participants in suboptimal, evaluating on the continuous A1C scores is more accurate for the 
present study. However, with the limited sample size, the current study has limited power. 
Therefore, while p=0.08 suggests trending toward significance, future studies require elevated 
sample size to explore this trend.  
A1C scores and adherence scores demonstrated statistical significance between the 
optimal and suboptimal groups. According to prior literature, the Self-Care Inventory is intended 





(Lewin et al., 2009). Therefore, this study indicates that the adherence measure performs as 
anticipated, even given the limited sample size.  
Adherence score linear regression demonstrated statistical significance with treatment 
type at p=0.03. As seen in Appendix C, the self-injection treatment type was associated with a -
0.54 drop in adherence score, on average. Prior literature, as well as this current study, suggests 
that a decrease in adherence scores would lead to poorer A1C outcomes (Lewin et al., 2009). 
However, this study showed that A1C scores were not affected by treatment type; even though 
self-injection treatment type led to a significant drop in adherence scores, this did not translate 
into elevated A1C scores (see in Appendix B). This could be due to the study’s smaller sample 
size, since it directly contradicts the logical association between treatment type and adherence 
scores, and adherence scores and A1C scores.   
Previous research has indicated that household income can affect the quality of disease 
management (Currie, 2009). Those with higher levels of income have access to more healthcare 
resources, better nutrition, and safe environments for exercise (Gorman & Braverman, 2008; 
Zarnowiecki et al., 2014). However, due to the preliminary nature of the study, the distribution 
along this categorical variable was skewed. In order to conduct analysis, income was grouped 
between over $75,000 and under $75,000. Due to the arbitrary cutoff, this grouping may not 
capture the potential effect of financial scarcity. Additionally, since household size was not 
considered in analyses, the recorded income may vary in financial worthiness between 
participants. Thus, income analyses are particularly preliminary.  
Race can impact disease management due to cultural effects, as well as financial resource 
availability (Jaser, 2011). The present study did not have enough observations from minority 





Prior research indicates that time elapsed since diagnosis can impact treatment 
management for individuals with T1D (Diabetes New Zealand, n.d.; 5 Facts, n.d.). However, 
there was no relationship between time since diagnosis and A1C scores (p=0.41). Potentially, 
since treatment is managed by a caregiver instead of by the individual, it could differ from the 
outcomes of prior research. Additionally, since the UNC Pediatric Diabetes Clinic is well-
resourced, caregivers may receive adequate treatment education to overcome potential 
experience gaps.  
Parental age can affect access to resources, as well as overall health outcomes of the child 
(Carslake et al., 2017; Zondervan-Zwijnenburg et al., 2020). However, the current study showed 
no relationship between parental age and A1C scores. Since all parents are receiving care from 
the UNC Pediatric Diabetes Clinic, the healthcare resources were uniform across participants. 
This could have eliminated any advantages stemming from advanced parental age.  
Additionally, treatment type was examined for its impact on the child’s A1C scores. 
Research demonstrates that utilizing the pump treatment methods results in lowered A1C scores, 
with around a 0.6% decrease in A1C from self-injection management (Bergenstal et al., 2010). In 
contrary, the present study did not demonstrate any statistically significant difference of A1C 
scores between children who used the pump and those with self-injection. This could be due to 
the elevated income levels of participants, which may increase health literacy and allow self-
injection scores to be lower than expected. Additionally, a relationship was found between 








Strengths and Limitations 
 The present study demonstrated several novel strengths. While the previous literature had 
extensively studied the effects of conscientiousness on the individual’s health, there is scant 
research concerning the transferability of conscientiousness from caretaker to care-receiver 
(Roberts et al., 2009). Thus, the study’s new approach to studying parent-to-child medical 
management is novel for the field.  
 However, while this study exhibited several strengths, there were notable weaknesses 
within the methodology. Firstly, the participant base was drawn solely from the UNC Pediatric 
Diabetes Clinic. While this clinic serves a wide variety of clients within the Chapel Hill area, the 
participant population was notably lacking in diversity. The sample was overwhelmingly white, 
middle-to-upper class, and female.  
Additionally, all potential participants received a recruitment email to complete this 
study. Those who elected to take the time to respond to the present study could have inherently 
different personality characteristics than the non-participants. For instance, the construct of 
conscientiousness includes six main factors: responsibility, order, virtue, industriousness, self-
control, and conventionality (Green et al., 2016). These qualities could lead an individual to 
recall the study invite and generate enough industriousness to complete it. Therefore, the 
participants who elected to complete the present study might not generalize to other parents of 
children with T1D, and this study may exhibit self-selection bias in its participants.  
Furthermore, the initial goal of the study was to separate all participants into two 
equivalent groups: optimal A1C and suboptimal A1C. However, the mean A1C of 8.23 indicates 
that this sample was significantly above the optimal cutoff of 7.5. Therefore, the two groups 





optimal group. When comparing these two-groups with a T-test analysis, the researcher is more 
limited due to the small sample size of the optimal group. This could have altered the study’s 
chance at statistical significance and impacted the central hypothesis of the research.  
Additionally, conscientiousness scores were clustered above average, given that the mean 
was 86.0, with a range of 75-99, and a SD of 9.54. Therefore, this positive tilt in response scores 
could have reduced the identifying power of the analysis.  
Importantly, the central goal of this study looked at conscientiousness scores effect on 
A1C scores. This data demonstrated insignificance at p=0.14. However, this study relies on self-
report measures. It is possible that individuals with trying to present themselves in the best 
possible light and their reported conscientiousness scores could deviate from true 
conscientiousness scores. While participants seemed to accurately self-report adherence scores, it 
is possible that conscientiousness is a less objective and specific self-report measure. For 
example, the Self-Care Inventory asked participants how often they carried quick acting sugar to 
treat reactions. This is an objective question with a specific, measurable answer. On the contrary, 
the IPIP Big Five Factor Measure for Conscientiousness inquired how often individuals do 
things in a halfway manner. This is much vaguer and more subjective than the questions on the 
adherence measure. Thus, there is more room for an individual to misreport in the 
conscientiousness measure than in the adherence measure. Potentially, future research could 
include a different measure of conscientiousness, the Implicit Association Test for 
Conscientiousness (Costantini et al, 2015). This measure accounts for potential self-report 
inaccuracy by altering the response mechanism. Instead of the participant deliberating on their 
response, the Implicit Association Test requires automatic and immediate answers to its 





Most importantly, the sample size of the current study was limited. Due to the novelty of 
this research, previous literature cannot provide an accurate estimated effect size. Therefore, 
power analysis to determine the desired sample size is difficult to complete. Additionally, with 
this study’s small sample size, limited power may be unable to identify the effect size.  The 
researcher contacted all potential participants given the criteria and attempted to recruit as many 
as possible. Despite this, the sample size of 30 fell short of the initial goal of 42 from the power 
analysis. In addition, this small sample size of 30 is at the threshold of when statisticians allow 
usage of the Central Limit Theorem. Therefore, utilizing large sample tests could bias the results, 
and the normality assumption had to be evaluated.     
Future Directions 
 In order to tackle the methodological shortcomings listed above, future studies on 
parental personality traits and T1D management in the child should recruit from more diverse 
populations. These future studies should consider alternative ways to recruit participants that will 
reduce non-response bias, since participants had to elect to complete the present study regardless 
of the ten to fifteen-minute time stressor.  
 Furthermore, future studies could recruit from populations that receive care in various 
clinics. The UNC Pediatric Diabetes Clinic is well-ranked and provides comprehensive care for 
its patients. In contrast, many children with T1D receive varying levels of attention and care 
from their treatment facility. By recruiting from various clinics with less comprehensive care, 
more rural populations, or higher poverty levels, the research might see effects from variables 
such as race or income.  
 Additionally, the present study did not identify significant associations between the 





it will be important to do a replication study with a larger sample size to ensure confidence in 
rejecting the hypothesis. The present study did not meet its initial goal of forty-two participants; 
due to a limited potential participant pool, the study managed to obtain thirty unique responses. 
Due to this low sample amount, the study’s power was reduced, and a larger study will be 
necessary to examine the validity of preliminary observations.  
 Furthermore, future studies should elect to use conscientiousness measures which are 
more objective and less prone to response-bias. This will ensure that scores are accurate 
indicators of the caregiver’s personal trait of conscientiousness.  
 Health literacy could be a confounding variable which impacts A1C scores in the child. 
Higher health literacy is associated with better disease management from caregiver to care-
receiver (Paschal et al., 2015). Therefore, it could potentially impact parental diabetes 
management for the child, and it should be investigated in replication studies.  
 Additionally, parental years of education could influence diabetes management in the 
child. In a similar study, higher parental education was associated with better outcomes in 
children with an asthma diagnosis (Strömberg et al., 2019). Potentially, a higher level of parental 
education could lead to quicker treatment understanding or overall increased health literacy. 
Therefore, this should be included in future studies to complement health literacy.  
 Importantly, given that the effect size may be relatively small, future studies must recruit 
participants required by the power analysis to accurately identify the effect.  
Conclusion 
 Overall, the results of the present study do not support parental conscientiousness as 
having an impact on T1D management in the child. Although similar studies suggested a 





positive health outcomes for the care-receiver, the current data demonstrates a weak relationship 
within the T1D population (Ma et al., 2018; Roberts et al., 2009). While parental 
conscientiousness did not affect A1C scores or adherence scores, adherence scores did 
demonstrate a statistically significant effect on A1C outcomes. Interestingly, higher 
conscientiousness scores have been linked to increased adherence scores in the individual in 
previous studies (Rassart et al., 2018; Wall et al., 2020). However, the current study explored the 
relatively new field of compensatory conscientiousness, which investigates how a caregiver’s 
personal conscientiousness impacts the care-receiver’s quality of treatment. Potentially, this 
connection between conscientiousness and adherence ceases to exist when it is evaluated from 
caregiver to care-receiver. This could suggest that compensatory conscientiousness does not 
influence treatment adherence and outcomes. Rather, the caregiver’s treatment adherence alone 
determines how well the care-receiver’s quality of treatment will be.  
However, further research on personality traits and the caregiver to care-receiver 
relationship should be investigated in future studies. Currently, parental conscientiousness does 
not seem to affect the quality of diabetes management for the child. Ultimately, this study 
provides illuminating data on parental conscientiousness and T1D management. Future research 















Participant characteristics by A1C grouping 
 
 






























 Optimal (A1C<=7.5) Suboptimal (A1C>7.5) 
Mean Adherence Score (SD) * 4.55 (0.31) 4.16 (0.63) 
Mean A1C 6.91 8.67 
Mean Conscientiousness (SD) 86.00 (9.54) 82.17 (9.99) 
Mean Parental Age  40.29 37.35 
Treatment Type:   
                             Self-Injection 3 12 
                             Pump 4 11 
Mean Years Since Diagnosis 4.00 3.74 
Mean Age at Diagnosis 4.29 3.61 







Linear Regression with A1C as Dependent Variable 
 
  A1C 
Predictors Estimates CI p 
(Intercept) 12.06 6.93 – 17.19 <0.001 
Conscientiousness_Score -0.03 -0.08 – 0.01 0.139 
Time_Since_Diagnosis 0.11 -0.16 – 0.37 0.414 
Child_Age 0.03 -0.18 – 0.25 0.760 
Treatment_Type 
[Self-Injection] 
0.49 -0.48 – 1.45 0.308 
Parent_Age -0.05 -0.13 – 0.03 0.189 
Income [Over 75,000] 0.26 -0.76 – 1.27 0.606 
Observations 30 





























Linear Regression with Adherence Score as Dependent Variable  
 
  Adherence_Score 
Predictors Estimates CI p 
(Intercept) 4.36 1.85 – 6.87 0.002 
Conscientiousness_Score 0.01 -0.02 – 0.03 0.492 
Time_Since_Diagnosis -0.10 -0.23 – 0.03 0.117 
Child_Age -0.02 -0.12 – 0.09 0.762 
Treatment_Type 
[Self-Injection] 
-0.54 -1.01 – -0.07 0.026 
Parent_Age 0.00 -0.04 – 0.04 0.902 
Income [Over 75,000] -0.14 -0.64 – 0.36 0.564 
Observations 30 





























Linear Regression with A1C as a Dependent Variable Controlling for Adherence Score  
 
  A1C 
Predictors Estimates CI p 
(Intercept) 14.90 8.67 – 21.14 <0.001 
Conscientiousness_Score -0.03 -0.08 – 0.02 0.195 
Adherence_Score -0.65 -1.51 – 0.21 0.129 
Time_Since_Diagnosis 0.04 -0.23 – 0.31 0.762 
Child_Age 0.02 -0.19 – 0.23 0.829 
Treatment_Type 
[Self-Injection] 
0.13 -0.91 – 1.18 0.794 
Parent_Age -0.05 -0.12 – 0.03 0.189 
Income [Over 75,000] 0.17 -0.83 – 1.16 0.733 
Observations 30 




























Logistical Regression with Focus on Conscientiousness as Primary Independent Variable  
 
  A1C_Group 
Predictors Odds Ratios CI p 
(Intercept) 0.00 0.00 – 0.51 0.072 
Conscientiousness_Score 1.07 0.97 – 1.21 0.215 
Time_Since_Diagnosis 0.79 0.39 – 1.40 0.441 
Treatment_Type 
[Self-Injection] 
0.46 0.04 – 3.76 0.485 
Child_Age 1.43 0.83 – 3.28 0.279 
Parent_Age 1.13 0.96 – 1.42 0.188 
Income [Over 75,000] 0.17 0.00 – 1.88 0.211 
Observations 30 





























Logistical Regression with Focus on Adherence Score as Primary Independent Variable  
  A1C_Group 
Predictors Odds Ratios CI p 
(Intercept) 0.00 0.00 – 0.03 0.051 
Adherence_Score 11.15 0.96 – 596.44 0.117 
Time_Since_Diagnosis 0.89 0.44 – 1.70 0.712 
Treatment_Type 
[Self-Injection] 
1.45 0.09 – 43.92 0.802 
Child_Age 1.33 0.81 – 2.82 0.325 
Parent_Age 1.12 0.95 – 1.44 0.241 
Income [Over 75,000] 0.34 0.02 – 4.12 0.416 
Observations 30 






























Logistical Regression with A1C Grouping as a Dependent Variable Controlling for Adherence 
Score 
  A1C_Group 
Predictors Odds Ratios CI p 
(Intercept) 0.00 0.00 – 0.00 0.045 
Conscientiousness_Score 1.08 0.96 – 1.26 0.251 
Adherence_Score 11.99 0.90 – 861.33 0.126 
Time_Since_Diagnosis 0.93 0.41 – 1.99 0.848 
Treatment_Type 
[Self-Injection] 
1.56 0.08 – 62.87 0.781 
Child_Age 1.41 0.82 – 3.22 0.286 
Parent_Age 1.15 0.96 – 1.58 0.236 
Income [Over 75,000] 0.16 0.00 – 2.82 0.287 
Observations 30 















































Dear Parent:    
    
We are conducting a research study titled “Parental Conscientiousness and Effective Disease 
Management in Children with Type 1 Diabetes”. We are contacting you because you have a 
child ten years old or under with type 1 diabetes who receives care at the UNC 
Pediatric Diabetes Clinic.     
    
This research investigates the correlation between the parent’s trait of conscientiousness and the 
child’s quality of diabetes management. We are currently recruiting 42 participants who are the 
primary-caregiving parents of a child ten years old or under with type 1 diabetes.     
    
Participation in this study involves:    
• 1-item screening survey    
• 20-item conscientiousness survey    
• 14-item child’s diabetes care survey    
• 8-item demographic and disease-specific survey    
    
The online study will take around 10-15 minutes to complete.     
    
To participate in the study, please click the link at the bottom of this email. You will begin the 1-
item screening survey, where, if you qualify, you will proceed to the consent form. If you choose 
to consent, you will begin the survey portion of the study.     
    
All participants who complete the study will receive a $10 Amazon e-gift card after data 
collection. If you have already completed the study, you will receive your $10 e-gift card via 
email following data collection.    
    
For more information about this study, please contact the principal investigator, Dr. Rák, via 
email at eniko_rak@med.unc.edu.    
    
Additionally, if you have questions or concerns, or if you would like to obtain information or 
offer input, please contact the Institutional Review Board at 919-966-3113 or by email 
to IRB_subjects@unc.edu.    
IRB study number: 20-1628    
    
Link to Study:      
https://docs.google.com/forms/d/e/1FAIpQLSfXJUdwBQPWETc24pkisqep8XefvDryETOnBln2
-ZSkUGGo0g/viewform?usp=sf_link    
    
Thank you,      









University of North Carolina at Chapel Hill 
Consent to Participate in a Research Study 
Adult Participants  
 
Consent Form Version Date: ______________ 
IRB Study # 20-1628 
Title of Study: Parental Conscientiousness and Effective Disease Management in Children with 
Type 1 Diabetes 
Principal Investigator: Eniko Rak 
Principal Investigator Department: Allied Health - Clinical Rehabilitation and Mental Health 
Counseling 
Principal Investigator Phone number: (919) 843-5138 




This study is comparing conscientiousness levels in parents and diabetes management in their 
children with type 1 diabetes. Participants will be sorted into one of two comparison groups 
based on the child’s A1C levels. Two short surveys will be administered via an online link in an 
email. One survey will focus on conscientiousness, and the other survey will focus on the child’s 
diabetes care. Finally, the participant will receive a form including demographic and disease-
specific questions.  
Participation should take around 15-20 minutes.  
Participants must be the primary-caregiving, English-speaking parent of a child with type 1 
diabetes.  
After study completion, the participant will be entered to win one of ten $10 Amazon e-gift 
cards. These gift cards will be administered after all data completion within the study is 
complete.  
This study has no known risks to the participant. 
What are some general things you should know about research studies? 





You may choose not to participate, or you may withdraw your consent to be in the study, for any 
reason, without penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.   You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies.  
Details about this study are discussed below.  It is important that you understand this information 
so that you can make an informed choice about being in this research study.  
 
You will be given a copy of this consent form.  You should ask the researchers named above, or 
staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study? 
 
The purpose of this research study is to understand the correlation between parental 
conscientiousness and the quality of diabetes management the child with type 1 diabetes 
receives. 
You are being asked to be in the study because you have a child age ten or under who has type 1 
diabetes.  
 
Are there any reasons you should not be in this study? 
You should not be in this study if you do not understand English, as the surveys will be written 
in English.  
 
How many people will take part in this study? 
Approximately 42 people at the UNC Pediatric Diabetes Clinic will take part in this study. 
 
 
How long will your part in this study last? 
The following surveys will take 15-20 minutes to complete. After finishing these surveys, your 
participation in the study will be complete.  
 
What will happen if you take part in the study? 
If you choose to take part in the study, you will be assigned to one of two groups. One 
group consists of parents of children with lower A1C scores. The other group consists of 
parents of children with higher A1C scores. You will not be informed about which group 
you are in, and there will be no identifying information linking you to either group.  
You will first receive a 20-item survey regarding conscientiousness. Next, you will receive a 14-
item survey asking about your child’s diabetes care. Throughout these two surveys, you may 
choose not to answer a question for any reason. Completing these two surveys is a requirement 
for participation within the study.  
Following the surveys, you will be asked several demographic questions, including your race, 





diabetes, including their age at diagnosis and their current age. Completing these forms on 
demographic questions is a requirement of participation in the study.  
After completing these questions, you will be thanked for your participation, and the study will 
be complete.  
What are the possible benefits from being in this study? 
 
Research is designed to benefit society by gaining new knowledge.  There is little chance you 
will benefit from being in this research study. 
 
What are the possible risks or discomforts involved from being in this study? 
 
This study has no known risks to the participant. However, there may be uncommon or 
previously unknown risks. You should report any problems to the researcher. 
 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might affect 
your willingness to continue your participation.  
 
How will information about you be protected? 
Privacy and confidentiality are critical for our research. All survey data will be stored within an 
encrypted Excel spreadsheet. Your survey responses will not be connected to any identifying 
information, such as your name or email address. ID numbers will be used in place of your name, 
and this will be kept within the encrypted Excel spreadsheet. Only the researchers will have 
access to the medical records data, including the A1C score, age of child, and contact 
information.  
Participants will not be identified in any report or publication about this study.  We may use de-
identified data and/or specimens from this study in future research without additional consent. 
Although every effort will be made to keep research records private, there may be times when 
federal or state law requires the disclosure of such records, including personal information.  This 
is very unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by 
law to protect the privacy of personal information.  In some cases, your information in this 
research study could be reviewed by representatives of the University, research sponsors, or 
government agencies (for example, the FDA) for purposes such as quality control or safety. 
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  If you are hurt, become 
sick, or develop a reaction from something that was done as part of this study, the researcher will 
help you get medical care, but the University of North Carolina at Chapel Hill has not set aside 





costs for medical expenses will be billed to you or your insurance company.  You may be 
responsible for any co-payments and your insurance may not cover the costs of study related 
injuries. 
If you think you have been injured from taking part in this study, call the Principal Investigator at 
the phone number provided on this consent form.  They will let you know what you should do.  
By signing this form, you do not give up your right to seek payment or other rights if you are 
harmed as a result of being in this study. 
What if you want to stop before your part in the study is complete? 
 
You can withdraw from this study at any time, without penalty. The investigators also have the 
right to stop your participation at any time. This could be because you have had an unexpected 
reaction, or have failed to follow instructions, or because the entire study has been stopped. 
If you withdraw or are withdrawn from this study all data collected will be destroyed and no 
additional data will be collected.  
Will you receive anything for being in this study? 
 
You will be receiving a chance at winning a $10 Amazon gift card for taking part in this study. If 
you withdraw from the study at any point, you will not be considered in the random drawing for 
the gift card, since all of your information will be immediately deleted. If you are randomly 
selected to receive one of the gift cards, you will receive an email from the researcher with a link 
to the e-gift card. The gift card selection will not occur until all data collection has ended.   
Any payment provided for participation in this study may be subject to applicable tax 
withholding obligations. 
 
Will it cost you anything to be in this study? 
It will not cost you anything to be in this study.  
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions about the study (including payments), complaints, concerns, or if a research-
related injury occurs, you should contact the researchers listed on the first page of this form. 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject, or if you 
would like to obtain information or offer input, you may contact the Institutional Review Board 







I have read the information provided above.  I have asked all the questions I have at this time.  I 
voluntarily agree to participate in this research study. 
 
______________________________________________________ 





















Signature of Witness if applicable; e.g. literacy issues, 
visually impaired, physically unable to sign, witness/interpreter for 
































Self-Care Inventory Parent Report 
 









IPIP Big Five Factor Markers for Conscientiousness 
 
Describe yourself as you generally are now, not as you wish to be in the future. Indicate for each 
statement whether it is 1. Very Inaccurate, 2. Moderately Inaccurate, 3. Neither Accurate nor 

















     
Do things in a half-
way manner 
     
Pay attention to 
details 
     
Find it difficult to 
get down to work 
     
Get chores done 
right away 
     
Like order      
Follow a schedule      
Leave my 
belongings around 
     
Shirk my duties      
Often forget to put 
things back in their 
proper place 
     
Am exacting in my 
work 
     
Do things 
according to a plan 
     









Like to tidy up      
Make a mess of 
things 
     
Neglect my duties      
Make plans and 
stick to them 
     
Love order and 
regularity 
     
Leave a mess in my 
room 












































b. Male  
c. Transgender Female 
d. Transgender Male 
e. Gender Variant/Non-Conforming 
f. Not Listed 









4. How would you describe yourself? 
a. American Indian or Alaska Native 
b. Asian 
c. Black or African American 
d. Native Hawaiian or Other Pacific Islander 
e. White 
 
5. What describes your household income? 





f. Over 100,000 
 
6. What age was your child at the time of diagnosis? 
a. ---- 
 
7. How old is your child now? 
a. ---- 
 
8. What does your child use for treatment management? Check all that apply.  
a. Pump 
b. Self-Injection 
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